Chugai Pharmaceutical Stock

JPY6,809.00

2.78%

Tokyo, Jul 22, 08:15 am CET

ISIN

JP3519400000

Symbol

4519

Index

Nikkei 225

Sector

Health

Industry

Pharmaceuticals

Overview Dividends Analysts Charts Strategies

Chugai Pharmaceutical Stock price

JPY6,781.00

+1,635.40 31.78% 5Y

Tokyo, Closing price Tue, Jul 22 2025

-223.00 3.18%

ISIN

JP3519400000

Symbol

4519

Index

Nikkei 225

Sector

Health

Industry

Pharmaceuticals

Key metrics

Basic

Market capitalization

JPY11.5t

Enterprise Value

JPY10.6t

Net debt

positive

Cash

JPY944.6b

Shares outstanding

1.6b

Valuation (TTM | estimate)

P/E

28.1 | 26.8

P/S

9.4 | 9.4

EV/Sales

8.7 | 8.6

EV/FCF

30.3

P/B

6.0

Dividends

DPS

JPY250.00

Yield 1Y | 5Y

1.4% | 1.8%

Growth 1Y | 5Y

3.1% | 12.9%

Payout 1Y | 3Y

41.2% | 38.4%

Increased

13 Years

Financials (TTM | estimate)

Revenue

JPY1.2t | JPY1.2t

EBITDA

- | JPY627.6b

EBIT

JPY578.8b | -

Net Income

JPY410.1b | JPY430.1b

Free Cash Flow

JPY348.4b

Growth (TTM | estimate)

Revenue

18.0% | 5.1%

EBITDA

- | 14.4%

EBIT

31.2% | -

Net Income

25.7% | 11.1%

Free Cash Flow

7.7%

Financial Health

Equity Ratio

86.1%

Return on Equity

20.4%

ROCE

30.0%

ROIC

Debt/Equity

0.0

EPS

JPY249.2

FCF per Share

JPY211.7

Short interest

Employees

Rev per Employee

JPY232.9m

As a Free StocksGuide user, you can view scores for all 7,010 stocks worldwide.

Get Started for Free Today

Chugai Pharmaceutical Stock Analysis

Unlock Scores for Free

??

20 Analysts have issued a Chugai Pharmaceutical forecast:

12x Buy

60%

8x Hold

40%

More details on Analyst Estimates Including Price Targets

20 Analysts have issued a Chugai Pharmaceutical forecast:

Buy

60%

Hold

40%

Analyst Estimates with Stock Price Targets

Financial data from Chugai Pharmaceutical

Income Statement P&L | Balance Sheet | Cash Flow

Quarter TTM Annually

Mar '25		+/- %
Revenue	1,222,121 1,222,121	18% 18% 100%
- Direct Costs	354,282 354,282	6% 6% 29%
Gross Profit	867,839 867,839	24% 24% 71%
- Selling and Administrative Expenses	110,749 110,749	3% 3% 9%
- Research and Development Expense	181,013 181,013	5% 5% 15%
EBITDA	- -	- -
- Depreciation and Amortization	- -	- -
EBIT (Operating Income) EBIT	578,779 578,779	31% 31% 47%
Net Profit	410,149 410,149	26% 26% 34%

In millions JPY.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Subscribe Now

Company Profile

Chugai Pharmaceutical Co., Ltd. engages in the research, development, manufacturing, sale, importation, and exportation of the pharmaceuticals. Its operations are carried out through the following business divisions: Research, Development, Production, Marketing, Medical Affairs and Drug Safety. The Research division focuses its efforts on creating innovative drugs by using its competitive strengths that include proprietary antibody technologies and cutting-edge research resources. The Development division provides cross-functional lifecycle management system to deliver innovative medicines to patients as quickly as possible. The Production division provides a world-class safety and quality management systems. The Marketing division conducts patient-oriented marketing activities to help solve issues related to healthcare. The Medical Affairs division works to properly deliver the value of medicines based on global compliance standards. The Drug Safety provides safety management system includes expert safety evaluation as well as timely gathering and reporting of safety information. The company was founded by Juzo Ueno on March 10, 1925 and is headquartered in Tokyo, Japan.

Head office	Japan
CEO	Osamu Okuda
Employees	5,026
Founded	1925
Website	www.chugai-pharm.co.jp

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now